Noninvasive Brain Stimulation to Enhance Cognition at Home Following a TBI.

NCT07428980 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2026-06-18

No results posted yet for this study

Summary

The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous vagus nerve stimulation (tVNS) at home, to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).

Conditions

  • TBI Traumatic Brain Injury

Interventions

DEVICE

Transcutaneous Vagus Nerve Stimulation (tVNS)

tVNS stimulation, one hour a day, for 14 days.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Shirley Ryan AbilityLab

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-09
Primary Completion
2026-04-27
Completion
2026-04-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07428980 on ClinicalTrials.gov